Semler Scientific Faces Class Action Lawsuit Over Securities Violations
PorAinvest
martes, 7 de octubre de 2025, 2:31 am ET1 min de lectura
SMLR--
The class action lawsuit, which has already been filed, seeks to recover damages on behalf of investors who may have suffered losses as a result of these alleged misrepresentations. Investors are encouraged to join the case by visiting the firm’s website or contacting the law firms representing the class action.
Bronstein, Gewirtz & Grossman, LLC [1] and Levi & Korsinsky, LLP [2] are the law firms handling the case. Both firms have extensive experience representing investors in complex securities litigation and have recovered hundreds of millions of dollars for their clients. Investors have until October 28, 2025, to request that the court appoint them as lead plaintiffs.
Investors who suffered losses in Semler Scientific securities during the relevant time frame are urged to contact the Schall Law Firm before October 29, 2025. Participation in the class action is free of cost, and any recovery will be shared among class members, with the law firms receiving a contingency fee if successful.
Semler Scientific is facing a class action lawsuit for alleged violations of securities laws. Investors who purchased the company's securities between March 10, 2021, and April 15, 2025, may be eligible to participate. The lawsuit claims that the company misrepresented its financial situation and misled investors. If you are a shareholder who suffered a loss, you are encouraged to contact the Schall Law Firm before October 29, 2025.
Semler Scientific, Inc. (NASDAQ: SMLR) is currently facing a class action lawsuit alleging violations of federal securities laws. The lawsuit, filed by investors who purchased the company's securities between March 10, 2021, and April 15, 2025, claims that Semler Scientific made materially false and/or misleading statements and failed to disclose significant information. This includes not disclosing a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act, while discussing potential violations in hypothetical terms.The class action lawsuit, which has already been filed, seeks to recover damages on behalf of investors who may have suffered losses as a result of these alleged misrepresentations. Investors are encouraged to join the case by visiting the firm’s website or contacting the law firms representing the class action.
Bronstein, Gewirtz & Grossman, LLC [1] and Levi & Korsinsky, LLP [2] are the law firms handling the case. Both firms have extensive experience representing investors in complex securities litigation and have recovered hundreds of millions of dollars for their clients. Investors have until October 28, 2025, to request that the court appoint them as lead plaintiffs.
Investors who suffered losses in Semler Scientific securities during the relevant time frame are urged to contact the Schall Law Firm before October 29, 2025. Participation in the class action is free of cost, and any recovery will be shared among class members, with the law firms receiving a contingency fee if successful.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios